Matches in SemOpenAlex for { <https://semopenalex.org/work/W3006840074> ?p ?o ?g. }
- W3006840074 endingPage "490" @default.
- W3006840074 startingPage "490" @default.
- W3006840074 abstract "Diffuse astrocytomas are the most aggressive and lethal glial tumors of the central nervous system (CNS). Their high cellular heterogeneity and the presence of specific barriers, i.e., blood–brain barrier (BBB) and tumor barrier, make these cancers poorly responsive to all kinds of currently available therapies. Standard therapeutic approaches developed to prevent astrocytoma progression, such as chemotherapy and radiotherapy, do not improve the average survival of patients. However, the recent identification of key genetic alterations and molecular signatures specific for astrocytomas has allowed the advent of novel targeted therapies, potentially more efficient and characterized by fewer side effects. Among others, peptides have emerged as promising therapeutic agents, due to their numerous advantages when compared to standard chemotherapeutics. They can be employed as (i) pharmacologically active agents, which promote the reduction of tumor growth; or (ii) carriers, either to facilitate the translocation of drugs through brain, tumor, and cellular barriers, or to target tumor-specific receptors. Since several pathways are normally altered in malignant gliomas, better outcomes may result from combining multi-target strategies rather than targeting a single effector. In the last years, several preclinical studies with different types of peptides moved in this direction, providing promising results in murine models of disease and opening new perspectives for peptide applications in the treatment of high-grade brain tumors." @default.
- W3006840074 created "2020-03-06" @default.
- W3006840074 creator A5023413714 @default.
- W3006840074 creator A5040678382 @default.
- W3006840074 creator A5071586379 @default.
- W3006840074 date "2020-02-20" @default.
- W3006840074 modified "2023-09-26" @default.
- W3006840074 title "Exploring Novel Molecular Targets for the Treatment of High-Grade Astrocytomas Using Peptide Therapeutics: An Overview" @default.
- W3006840074 cites W1600432148 @default.
- W3006840074 cites W1706016362 @default.
- W3006840074 cites W1778412215 @default.
- W3006840074 cites W1902577542 @default.
- W3006840074 cites W1976659174 @default.
- W3006840074 cites W1985901101 @default.
- W3006840074 cites W1992450378 @default.
- W3006840074 cites W1998390678 @default.
- W3006840074 cites W2008173042 @default.
- W3006840074 cites W2009068601 @default.
- W3006840074 cites W2009309403 @default.
- W3006840074 cites W2019874130 @default.
- W3006840074 cites W2033803049 @default.
- W3006840074 cites W2039243233 @default.
- W3006840074 cites W2050605813 @default.
- W3006840074 cites W2052816585 @default.
- W3006840074 cites W2053426906 @default.
- W3006840074 cites W2071817077 @default.
- W3006840074 cites W2073188392 @default.
- W3006840074 cites W2076704022 @default.
- W3006840074 cites W2078411682 @default.
- W3006840074 cites W2084621409 @default.
- W3006840074 cites W2088877201 @default.
- W3006840074 cites W2095971387 @default.
- W3006840074 cites W2101922439 @default.
- W3006840074 cites W2104618032 @default.
- W3006840074 cites W2108688211 @default.
- W3006840074 cites W2111631341 @default.
- W3006840074 cites W2117735955 @default.
- W3006840074 cites W2136007332 @default.
- W3006840074 cites W2139709150 @default.
- W3006840074 cites W2143897427 @default.
- W3006840074 cites W2147000598 @default.
- W3006840074 cites W2254511517 @default.
- W3006840074 cites W2296095373 @default.
- W3006840074 cites W2302642120 @default.
- W3006840074 cites W2341241911 @default.
- W3006840074 cites W2366536035 @default.
- W3006840074 cites W2401766624 @default.
- W3006840074 cites W2405638522 @default.
- W3006840074 cites W2409434001 @default.
- W3006840074 cites W2463573997 @default.
- W3006840074 cites W2463925963 @default.
- W3006840074 cites W2476928664 @default.
- W3006840074 cites W2489012250 @default.
- W3006840074 cites W2516432787 @default.
- W3006840074 cites W2564096649 @default.
- W3006840074 cites W2588262749 @default.
- W3006840074 cites W2598922467 @default.
- W3006840074 cites W2603655232 @default.
- W3006840074 cites W2606480134 @default.
- W3006840074 cites W2612937659 @default.
- W3006840074 cites W2617111840 @default.
- W3006840074 cites W2624516058 @default.
- W3006840074 cites W2625826824 @default.
- W3006840074 cites W2750074602 @default.
- W3006840074 cites W2751602375 @default.
- W3006840074 cites W2752314762 @default.
- W3006840074 cites W2756591964 @default.
- W3006840074 cites W2761599107 @default.
- W3006840074 cites W2763367287 @default.
- W3006840074 cites W2775828105 @default.
- W3006840074 cites W2783146090 @default.
- W3006840074 cites W2787278337 @default.
- W3006840074 cites W2790271793 @default.
- W3006840074 cites W2800333829 @default.
- W3006840074 cites W2807650295 @default.
- W3006840074 cites W2811180866 @default.
- W3006840074 cites W2884741638 @default.
- W3006840074 cites W2892115080 @default.
- W3006840074 cites W2899363944 @default.
- W3006840074 cites W2899509963 @default.
- W3006840074 cites W2906075703 @default.
- W3006840074 cites W2909505816 @default.
- W3006840074 cites W2920264076 @default.
- W3006840074 cites W2938422897 @default.
- W3006840074 cites W2944047957 @default.
- W3006840074 cites W2966374347 @default.
- W3006840074 cites W2967940492 @default.
- W3006840074 cites W2980729449 @default.
- W3006840074 cites W2982861304 @default.
- W3006840074 doi "https://doi.org/10.3390/cells9020490" @default.
- W3006840074 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7072800" @default.
- W3006840074 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32093304" @default.
- W3006840074 hasPublicationYear "2020" @default.
- W3006840074 type Work @default.
- W3006840074 sameAs 3006840074 @default.
- W3006840074 citedByCount "7" @default.
- W3006840074 countsByYear W30068400742020 @default.
- W3006840074 countsByYear W30068400742021 @default.